Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2- HIV Infection”

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT00381017
What this trial is testing

Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)

Who this might be right for
Hepatitis CLiver CirrhosisHIV Infections
Merck Sharp & Dohme LLC
Not applicableStudy completedNCT03401697
What this trial is testing

Eliminating Hepatitis C Virus

Who this might be right for
Hepatitis CHIVType2 Diabetes
Icahn School of Medicine at Mount Sinai 52
Large-scale testing (Phase 3)UnknownNCT05735535
What this trial is testing

Women in Dual With Dolutegravir

Who this might be right for
HIV Infections
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 290
Early research (Phase 1)Study completedNCT06033547
What this trial is testing

Investigate the Pharmacokinetics, Safety, and Tolerability of Two Different Formulations of Long-acting Cabotegravir in Healthy Adult Participants

Who this might be right for
HIV Infections
ViiV Healthcare 56
Early research (Phase 1)Study completedNCT01308658
What this trial is testing

TMC114-TiDP3-C176 - A Study in Healthy Volunteers Investigating the Bioequivalence Between Two Commercially Available 400-mg Tablets to One New 800-mg Tablet of Darunavir (DRV) in the Presence of Low-dose Ritonavir Under Fed and Fasted Conditions

Who this might be right for
Healthy
Tibotec Pharmaceuticals, Ireland 128
Testing effectiveness (Phase 2)UnknownNCT03281226
What this trial is testing

RIPE vs RIPE Plus N-acetylcysteine in Patients With HIV/TB Co-infection

Who this might be right for
Tuberculosis, PulmonaryHIV/AIDS
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado 50
Early research (Phase 1)Study completedNCT00000974
What this trial is testing

Two Forms of Pentamidine in HIV-Infected Children Who May Have Pneumocystis Carinii Pneumonia

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 16
Early research (Phase 1)Study completedNCT00000958
What this trial is testing

A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 8
Not applicableStudy completedNCT00567749
What this trial is testing

Clinical Sensitivity of Clearview Rapid Tests in 12-17 y/o Pediatric Population

Who this might be right for
HIV Infections
Chembio Diagnostic Systems, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT02452242
What this trial is testing

Safety, PK and PD Study of ABX464 in Untreated HIV Patients

Who this might be right for
Human Immunodeficiency Virus Infections
Abivax S.A. 70
Early research (Phase 1)Study completedNCT03234036
What this trial is testing

A Two-part Study to Compare a Tablet and Capsule Formulation of GSK2838232 With and Without Food, and to Assess the Safety and Drug Levels of Repeated Once-daily Doses of GSK2838232 Without Ritonavir

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
GlaxoSmithKline 26
Early research (Phase 1)Study completedNCT02277600
What this trial is testing

Antiretroviral Drug-Drug Interaction Study in Healthy Volunteers (DDI)

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 32
Not applicableWithdrawnNCT01381146
What this trial is testing

Victim Impact Modules for Jail Inmates

Who this might be right for
Substance AbuseHIV RiskShame+3 more
George Mason University
Not applicableStudy completedNCT04117984
What this trial is testing

Swaziland HIV Incidence Measurement Survey 2

Who this might be right for
HIV/AIDS
Columbia University 15,429
Not applicableStudy completedNCT01322932
What this trial is testing

Tenofovir, Emtricitabine and Efavirenz Late Switch to a Single Pill: Patients' Opinion Survey

Who this might be right for
HIV Infection
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland 95
Large-scale testing (Phase 3)Study completedNCT02478632
What this trial is testing

Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen

Who this might be right for
HIV Infections
ViiV Healthcare 102
Not applicableStudy completedNCT00004855
What this trial is testing

Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Testing effectiveness (Phase 2)Study completedNCT00102206
What this trial is testing

A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 6
Testing effectiveness (Phase 2)Study completedNCT02480387
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 8 Weeks in Subjects With Chronic Genotype 1 HCV and HIV-1 Co-infection

Who this might be right for
Treatment of Hepatitis C
Peter J. Ruane, M.D., Inc. 20
Testing effectiveness (Phase 2)Study completedNCT05112848
What this trial is testing

Evaluate Safety and Immunogenicity of a COVID-19 Vaccine in People Living With HIV at Risk for SARS-CoV-2 (COVID-19)

Who this might be right for
SARS-CoV-2 Infection
Novavax 384
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation